Alzheimer's disease research progress in the Mediterranean region: The Alzheimer's Association International Conference Satellite Symposium.
Alzheimer's disease
biomarkers
care
dementia
genetics
prevention
Journal
Alzheimer's & dementia : the journal of the Alzheimer's Association
ISSN: 1552-5279
Titre abrégé: Alzheimers Dement
Pays: United States
ID NLM: 101231978
Informations de publication
Date de publication:
10 2022
10 2022
Historique:
revised:
14
12
2021
received:
30
08
2021
accepted:
16
12
2021
pubmed:
21
2
2022
medline:
21
10
2022
entrez:
20
2
2022
Statut:
ppublish
Résumé
As research and services in the Mediterranean region continue to increase, so do opportunities for global collaboration. To support such collaborations, the Alzheimer's Association was due to hold its seventh Alzheimer's Association International Conference Satellite Symposium in Athens, Greece in 2021. Due to the COVID-19 pandemic, the meeting was held virtually, which enabled attendees from around the world to hear about research efforts in Greece and the surrounding Mediterranean countries. Research updates spanned understanding the biology of, treatments for, and care of people with Alzheimer's disease (AD_ and other dementias. Researchers in the Mediterranean region have outlined the local epidemiology of AD and dementia, and have identified regional populations that may expedite genetic studies. Development of biomarkers is expected to aid early and accurate diagnosis. Numerous efforts have been made to develop culturally specific interventions to both reduce risk of dementia, and to improve quality of life for people living with dementia.
Substances chimiques
Biomarkers
0
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
1957-1968Subventions
Organisme : NIA NIH HHS
ID : R01 AG057234
Pays : United States
Informations de copyright
© 2022 The Authors. Alzheimer's & Dementia published by Wiley Periodicals LLC on behalf of Alzheimer's Association.
Références
Niu H, Álvarez-Álvarez I, Guillén-Grima F, Aguinaga-Ontoso I. Prevalence and incidence of Alzheimer's disease in Europe: a meta-analysis. Neurol Barc Spain. 2017;32:523-532. https://doi.org/10.1016/j.nrl.2016.02.016
Kosmidis MH, Vlachos GS, Anastasiou CA, et al. Dementia Prevalence in Greece: the Hellenic Longitudinal Investigation of Aging and Diet (HELIAD). Alzheimer Dis Assoc Disord. 2018;32:232-239. https://doi.org/10.1097/WAD.0000000000000249
Vlachos GS, Kosmidis MH, Yannakoulia M, et al. Dementia Incidence in the Elderly Population of Greece: results From the HELIAD Study. Alzheimer Dis Assoc Disord. 2021;35:48-54. https://doi.org/10.1097/WAD.0000000000000407
Vlachos GS, Kosmidis MH, Yannakoulia M, et al. Prevalence of Mild Cognitive Impairment in the Elderly Population in Greece: results From the HELIAD Study. Alzheimer Dis Assoc Disord. 2020;34:156-162. https://doi.org/10.1097/WAD.0000000000000361
GBD 2016 Dementia Collaborators. Global, regional, and national burden of Alzheimer's disease and other dementias, 1990-2016: a systematic analysis for the Global Burden of Disease Study 2016. Lancet Neurol 2019;18:88-106. https://doi.org/10.1016/S1474-4422(18)30403-4
Fratiglioni L, Launer LJ, Andersen K, et al. Incidence of dementia and major subtypes in Europe: a collaborative study of population-based cohorts. Neurologic Diseases in the Elderly Research Group. Neurology. 2000;54:S10-S15.
Charisis S, Ntanasi E, Yannakoulia M, et al. Mediterranean diet and risk for dementia and cognitive decline in a Mediterranean population. J Am Geriatr Soc. 2021;69:1548-1559. https://doi.org/10.1111/jgs.17072
Naska A, Oikonomou E, Trichopoulou A, Psaltopoulou T, Trichopoulos D. Siesta in healthy adults and coronary mortality in the general population. Arch Intern Med. 2007;167:296-301. https://doi.org/10.1001/archinte.167.3.296
Lozupone M, Sardone R, Donghia R, et al. Late-onset depression is associated to age-related central auditory processing disorder in an older population in Southern Italy. GeroScience. 2020;43:1003-1014. https://doi.org/10.1007/s11357-020-00290-1
Chadjikyprianou A, Hadjivassiliou M, Papacostas S, Constantinidou F. The Neurocognitive Study for the Aging: longitudinal Analysis on the Contribution of Sex, Age, Education and APOE ɛ4 on Cognitive Performance. Front Genet. 2021;12:680531. https://doi.org/10.3389/fgene.2021.680531
Scarmeas N, Stern Y, Tang M-X, Mayeux R, Luchsinger JA. Mediterranean diet and risk for Alzheimer's disease. Ann Neurol. 2006;59:912-921. https://doi.org/10.1002/ana.20854
Brickman AM, Manly JJ, Honig LS, et al. Plasma p-tau181, p-tau217, and other blood-based Alzheimer's disease biomarkers in a multi-ethnic, community study. Alzheimers Dement J Alzheimers Assoc. 2021;17:1353-1364. https://doi.org/10.1002/alz.12301
Tsolaki AC, Gatzima O, Daniilidou M, et al. Prevalence of Apolipoprotein E Polymorphisms in Alzheimer's Disease, Mild Cognitive Impairment, and Healthy Elderly: a Northern Greece Study. Neurodegener Dis. 2018;18:216-224. https://doi.org/10.1159/000491764
Pastor P, Moreno F, Clarimón J, et al. MAPT H1 Haplotype is Associated with Late-Onset Alzheimer's Disease Risk in APOEɛ4 Noncarriers: results from the Dementia Genetics Spanish Consortium. J Alzheimers Dis JAD. 2016;49:343-352. https://doi.org/10.3233/JAD-150555
Moreno F, Indakoetxea B, Barandiaran M, et al. The unexpected co-occurrence of GRN and MAPT p.A152T in Basque families: clinical and pathological characteristics. PloS One. 2017;12:e0178093. https://doi.org/10.1371/journal.pone.0178093
Sánchez-Juan P, Moreno S, de Rojas I, et al. The MAPT H1 Haplotype Is a Risk Factor for Alzheimer's Disease in APOE ε4 Non-carriers. Front Aging Neurosci. 2019;11:327. https://doi.org/10.3389/fnagi.2019.00327
Guven G, Lohmann E, Bras J, et al. Mutation Frequency of the Major Frontotemporal Dementia Genes, MAPT, GRN and C9ORF72 in a Turkish Cohort of Dementia Patients. PloS One. 2016;11:e0162592. https://doi.org/10.1371/journal.pone.0162592
Guerreiro RJ, Lohmann E, Brás JM, et al. Using exome sequencing to reveal mutations in TREM2 presenting as a frontotemporal dementia-like syndrome without bone involvement. JAMA Neurol. 2013;70:78-84. https://doi.org/10.1001/jamaneurol.2013.579
Kartanou C, Karadima G, Koutsis G, et al. Screening for the C9ORF72 repeat expansion in a greek frontotemporal dementia cohort. Amyotroph Lateral Scler Front Degener. 2018;19:152-154. https://doi.org/10.1080/21678421.2017.1400070
Ramos EM, Koros C, Dokuru DR, et al. Frontotemporal dementia spectrum: first genetic screen in a Greek cohort. Neurobiol Aging. 2019;75:224.e1-224.e8. https://doi.org/10.1016/j.neurobiolaging.2018.10.029
Darwich NF, Phan JM, Kim B, et al. Autosomal dominant VCP hypomorph mutation impairs disaggregation of PHF-tau. Science. 2020;370:eaay8826. https://doi.org/10.1126/science.aay8826
Charoniti E, Papastefanopoulou V, Florou-Hatziyiannidou C, et al. TARDBP p.I383V, a recurrent alteration in Greek FTD patients. J Neurol Sci. 2021;428:117566. https://doi.org/10.1016/j.jns.2021.117566
Moore KM, Nicholas J, Grossman M, et al. Age at symptom onset and death and disease duration in genetic frontotemporal dementia: an international retrospective cohort study. Lancet Neurol. 2020;19:145-156. https://doi.org/10.1016/S1474-4422(19)30394-1
Werner K, Müller J, Husum K, Spielhagen RF, Kandiano ES, Polyak L. Sedimentology on core MSM05/05_723-2. Suppl Werner K Al 2015 Holocene Sea Subsurf Surf Water Masses Fram Strait - Comp Temp Sea-Ice Reconstr PAST Gatew Spec Issue JQSR4428. Quat Sci Rev. 2015. https://doi.org.101016jquascirev201509007
Specktor P, Ben Hayun R, Yarovinsky N, Fisher T, Aharon Peretz J. Ethnic Differences in Attending a Tertiary Dementia Clinic in Israel. Front Neurol. 2020;11:578068. https://doi.org/10.3389/fneur.2020.578068
McCarron M, McCallion P, Reilly E, Dunne P, Carroll R, Mulryan N. A prospective 20-year longitudinal follow-up of dementia in persons with Down syndrome. J Intellect Disabil Res JIDR. 2017;61:843-852. https://doi.org/10.1111/jir.12390
Benejam B, Videla L, Vilaplana E, et al. Diagnosis of prodromal and Alzheimer's disease dementia in adults with Down syndrome using neuropsychological tests. Alzheimers Dement Amst Neth. 2020;12:e12047. https://doi.org/10.1002/dad2.12047
Lott IT, Head E. Dementia in Down syndrome: unique insights for Alzheimer disease research. Nat Rev Neurol. 2019;15:135-147. https://doi.org/10.1038/s41582-018-0132-6
Fortea J, Vilaplana E, Carmona-Iragui M, et al. Clinical and biomarker changes of Alzheimer's disease in adults with Down syndrome: a cross-sectional study. Lancet Lond Engl. 2020;395:1988-1997. https://doi.org/10.1016/S0140-6736(20)30689-9
Fortea J, Carmona-Iragui M, Benejam B, et al. Plasma and CSF biomarkers for the diagnosis of Alzheimer's disease in adults with Down syndrome: a cross-sectional study. Lancet Neurol. 2018;17:860-869. https://doi.org/10.1016/S1474-4422(18)30285-0
Carmona-Iragui M, Alcolea D, Barroeta I, et al. Diagnostic and prognostic performance and longitudinal changes in plasma neurofilament light chain concentrations in adults with Down syndrome: a cohort study. Lancet Neurol. 2021;20:605-614. https://doi.org/10.1016/S1474-4422(21)00129-0
Benzinger TLS, Blazey T, Jack CR, et al. Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease. Proc Natl Acad Sci U S A. 2013;110:E4502-E4509. https://doi.org/10.1073/pnas.1317918110
Preische O, Schultz SA, Apel A, et al. Serum neurofilament dynamics predicts neurodegeneration and clinical progression in presymptomatic Alzheimer's disease. Nat Med. 2019;25:277-283. https://doi.org/10.1038/s41591-018-0304-3
Washington University School of Medicine. A Phase II/III Randomized, Double-Blind, Placebo-Controlled, Cognitive Endpoint, Multi-Center Study of Potential Disease Modifying Therapies in Individuals at Risk for and With Dominantly Inherited Alzheimer's Disease. clinicaltrials.gov; 2020.
Apostolova LG, Aisen P, Eloyan A, et al. The Longitudinal Early-onset Alzheimer's Disease Study (LEADS): framework and methodology. Alzheimers Dement J Alzheimers Assoc. 2021;17:2043-2055. https://doi.org/10.1002/alz.12350
Molinuevo JL, Gramunt N, Gispert JD, et al. The ALFA project: a research platform to identify early pathophysiological features of Alzheimer's disease. Alzheimers Dement N Y N. 2016;2:82-92. https://doi.org/10.1016/j.trci.2016.02.003
Milà-Alomà M, Salvadó G, Gispert JD, et al. Amyloid beta, tau, synaptic, neurodegeneration, and glial biomarkers in the preclinical stage of the Alzheimer's continuum. Alzheimers Dement J Alzheimers Assoc. 2020;16:1358-1371. https://doi.org/10.1002/alz.12131
van Maurik IS, Vos SJ, Bos I, et al. Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study. Lancet Neurol. 2019;18:1034-1044. https://doi.org/10.1016/S1474-4422(19)30283-2
Babiloni C, Del Percio C, Boccardi M, et al. Occipital sources of resting-state alpha rhythms are related to local gray matter density in subjects with amnesic mild cognitive impairment and Alzheimer's disease. Neurobiol Aging. 2015;36:556-570. https://doi.org/10.1016/j.neurobiolaging.2014.09.011
Şeker M, Özbek Y, Yener G, Özerdem MS. Complexity of EEG Dynamics for Early Diagnosis of Alzheimer's Disease Using Permutation Entropy Neuromarker. Comput Methods Programs Biomed. 2021;206:106116. https://doi.org/10.1016/j.cmpb.2021.106116
Yener GG, Emek-Savaş DD, Güntekin B, Başar E. The visual cognitive network, but not the visual sensory network, is affected in amnestic mild cognitive impairment: a study of brain oscillatory responses. Brain Res. 2014;1585:141-149. https://doi.org/10.1016/j.brainres.2014.08.038
Leontjevas R, Knippenberg IAH, Smalbrugge M, et al. Challenging behavior of nursing home residents during COVID-19 measures in the Netherlands. Aging Ment Health. 2021;25:1314-1319. https://doi.org/10.1080/13607863.2020.1857695
Lichtwarck B, Selbaek G, Kirkevold Ø, et al. Targeted Interdisciplinary Model for Evaluation and Treatment of Neuropsychiatric Symptoms: a Cluster Randomized Controlled Trial. Am J Geriatr Psychiatry Off J Am Assoc Geriatr Psychiatry. 2018;26:25-38. https://doi.org/10.1016/j.jagp.2017.05.015
Lichtwarck B, Myhre J, Selbaek G, et al. TIME to reduce agitation in persons with dementia in nursing homes. A process evaluation of a complex intervention. BMC Health Serv Res. 2019;19:349. https://doi.org/10.1186/s12913-019-4168-0
Birkenhäger-Gillesse EG, Kollen BJ, Achterberg WP, Boersma F, Jongman L, Zuidema SU. Effects of Psychosocial Interventions for Behavioral and Psychological Symptoms in Dementia on the Prescription of Psychotropic Drugs: a Systematic Review and Meta-Analyses. J Am Med Dir Assoc. 2018;19:276.e1-276.e9. https://doi.org/10.1016/j.jamda.2017.12.100
Chatzikyprianou A, Constantinidou F. The Impact of Hearing Loss on Cognitive Performance in Adulthood: findings From the NEUROAGE Project. Arch Phys Med Rehabil. 2018;99:e37. https://doi.org/10.1016/j.apmr.2018.07.129
Leroi I, Simkin Z, Hooper E, et al. Impact of an intervention to support hearing and vision in dementia: the SENSE-Cog Field Trial. Int J Geriatr Psychiatry. 2020;35:348-357. https://doi.org/10.1002/gps.5231
Scarmeas N, Anastasiou CA, Yannakoulia M. Nutrition and prevention of cognitive impairment. Lancet Neurol. 2018;17:1006-1015. https://doi.org/10.1016/S1474-4422(18)30338-7
Valls-Pedret C, Sala-Vila A, Serra-Mir M, et al. Mediterranean Diet and Age-Related Cognitive Decline: a Randomized Clinical Trial. JAMA Intern Med. 2015;175:1094-1103. https://doi.org/10.1001/jamainternmed.2015.1668
Anastasiou CA, Yannakoulia M, Kosmidis MH, et al. Mediterranean diet and cognitive health: initial results from the Hellenic Longitudinal Investigation of Ageing and Diet. PloS One. 2017;12:e0182048. https://doi.org/10.1371/journal.pone.0182048
Osorio RS, Gumb T, Pirraglia E, et al. Sleep-disordered breathing advances cognitive decline in the elderly. Neurology. 2015;84:1964-1971. https://doi.org/10.1212/WNL.0000000000001566
La AL, Walsh CM, Neylan TC, et al. Long-Term Trazodone Use and Cognition: a Potential Therapeutic Role for Slow-Wave Sleep Enhancers. J Alzheimers Dis JAD. 2019;67:911-921. https://doi.org/10.3233/JAD-181145
Livingston G, Huntley J, Sommerlad A, et al. Dementia prevention, intervention, and care: 2020 report of the Lancet Commission. Lancet Lond Engl. 2020;396:413-446. https://doi.org/10.1016/S0140-6736(20)30367-6
Kouloutbani K, Venetsanou F, Markati A, Karteroliotis KE, Politis A. The effectiveness of physical exercise interventions in the management of neuropsychiatric symptoms in dementia patients: a systematic review. Int Psychogeriatr. 2021:1-14. https://doi.org/10.1017/S1041610221000193
Pahor M, Guralnik JM, Ambrosius WT, et al. Effect of structured physical activity on prevention of major mobility disability in older adults: the LIFE study randomized clinical trial. JAMA. 2014;311:2387-2396. https://doi.org/10.1001/jama.2014.5616
Stathi A, Withall J, Greaves CJ, et al. A community-based physical activity intervention to prevent mobility-related disability for retired older people (REtirement in ACTion (REACT)): study protocol for a randomised controlled trial. Trials. 2018;19:228. https://doi.org/10.1186/s13063-018-2603-x
Stathi A, Withall J, Greaves C, et al. A randomised controlled trial and economic evaluation of a community-based physical activity intervention to prevent mobility-related disability in older adults: the REACT [REtirement in ACTion] study. Public Health Res. n.d.
Bamidis PD, Fissler P, Papageorgiou SG, et al. Gains in cognition through combined cognitive and physical training: the role of training dosage and severity of neurocognitive disorder. Front Aging Neurosci. 2015;7:152. https://doi.org/10.3389/fnagi.2015.00152
Tsolaki M, Kounti F, Agogiatou C, et al. Effectiveness of nonpharmacological approaches in patients with mild cognitive impairment. Neurodegener Dis. 2011;8:138-145. https://doi.org/10.1159/000320575
Poptsi E, Tsatali M, Agogiatou C, et al. Longitudinal Cognitive and Physical Training Effectiveness in MCI, Based on the Experience of the Alzheimer's Hellas Day Care Centre. J Geriatr Psychiatry Neurol. 2021:8919887211016057. https://doi.org/10.1177/08919887211016057
Zygouris S, Giakoumis D, Votis K, et al. Can a virtual reality cognitive training application fulfill a dual role? Using the virtual supermarket cognitive training application as a screening tool for mild cognitive impairment. J Alzheimers Dis JAD. 2015;44:1333-1347. https://doi.org/10.3233/JAD-141260
Zygouris S, Ntovas K, Giakoumis D, et al. A Preliminary Study on the Feasibility of Using a Virtual Reality Cognitive Training Application for Remote Detection of Mild Cognitive Impairment. J Alzheimers Dis. 2017;56:619-627. https://doi.org/10.3233/JAD-160518
Zygouris S, Iliadou P, Lazarou E, et al. Detection of Mild Cognitive Impairment in an At-Risk Group of Older Adults: can a Novel Self-Administered Serious Game-Based Screening Test Improve Diagnostic Accuracy? J Alzheimers Dis. 2020;78:405-412. https://doi.org/10.3233/JAD-200880
Iliadou P, Paliokas I, Zygouris S, et al. A Comparison of Traditional and Serious Game-Based Digital Markers of Cognition in Older Adults with Mild Cognitive Impairment and Healthy Controls. J Alzheimers Dis. 2021;79:1747-1759. https://doi.org/10.3233/JAD-201300
Eraslan Boz H, Limoncu H, Zygouris S, Tsolaki M, et al. A new tool to assess amnestic mild cognitive impairment in Turkish older adults: virtual supermarket (VSM). Aging Neuropsychol Cogn. 2020;27:639-653. https://doi.org/10.1080/13825585.2019.1663146
Limoncu H, Boz HE, Zygouris S, et al. A Virtual Reality-Based Screening Test for Cognitive Impairment in Small Vessel Disease. J Alzheimers Dis Rep. 2021;5:161-169. https://doi.org/10.3233/ADR-200257
Zygouris S, Gkioka M, Moraitou D, et al. Views of nursing staff on computerized dementia screening. Z Für Gerontol Geriatr. 2019;52:258-263. https://doi.org/10.1007/s00391-019-01633-0
Zygouris S, Gkioka M, Moraitou D, et al. Assessing the Attitudes of Greek Nurses Toward Computerized Dementia Screening. J Alzheimers Dis. 2020;78:1575-1583. https://doi.org/10.3233/JAD-200666
Poptsi E, Moraitou D, Tsardoulias E, Symeonidisd AL, Tsolaki M. Is the Discrimination of Subjective Cognitive Decline from Cognitively Healthy Adulthood and Mild Cognitive Impairment Possible? A Pilot Study Utilizing the R4Alz Battery. J Alzheimers Dis JAD. 2020;77:715-732. https://doi.org/10.3233/JAD-200562
International AD, Zeisel J, Bennett K, Fleming R, World Alzheimer Report 2020: design, dignity, dementia: dementia-related design and the built environment 2020.
cmarinos. Driverbrain. NRSO n.d. https://www.nrso.ntua.gr/driverbrain/ (Accessed June 24, 2021).
Fragkiadaki S, Beratis IN, Kontaxopoulou D, et al. Self-awareness of Driving Ability in the Healthy Elderly and Patients With Mild Cognitive Impairment (MCI). Alzheimer Dis Assoc Disord. 2018;32:107-113. https://doi.org/10.1097/WAD.0000000000000254
Beratis IN, Pavlou D, Papadimitriou E, et al. Mild Cognitive Impairment and driving: does in-vehicle distraction affect driving performance? Accid Anal Prev. 2017;103:148-155. https://doi.org/10.1016/j.aap.2017.03.014
Beratis IN, Andronas N, Kontaxopoulou D, et al. Driving in mild cognitive impairment: the role of depressive symptoms. Traffic Inj Prev. 2017;18:470-476. https://doi.org/10.1080/15389588.2016.1265648
Establishing Geriatric Services: the Success Story of Ain Shams University -Egypt. Egypt J Geriatr Gerontol 2019;6:8-21. https://doi.org/10.21608/ejgg.2019.139013
Hassanin HI, Tawfik HM, Zygouris S, Tsatali M, Sweed HS, Tsolaki M. Setting Up a Cognitive Training Service for Egyptian Older Adults. J Alzheimers Dis JAD. 2021;79:1673-1682. https://doi.org/10.3233/JAD-201278
Tawfik HM, Tsatali M, Hassanin HI. Pilot feasibility study of cognitive training exercises for Egyptian adults: proof of concept. Int J Geriatr Psychiatry. https://doi.org/10.1002/gps.5624. n.d.;n/a.